Vulnerability of the spinal motor neuron presynaptic terminal sub-proteome in ALS - PubMed

Vulnerability of the spinal motor neuron presynaptic terminal sub-proteome in ALS

Jeremy S Lum et al. Neurosci Lett. 2022.

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder, characterised by the loss of motor neurons and subsequent paralysis. Evidence indicates that synaptic alterations are associated with the early stages of ALS pathogenesis. A hallmark of ALS postmortem tissue is the presence of proteinaceous inclusions, indicative of disturbed protein homeostasis, particularly in spinal cord motor neurons. We recently demonstrated that spinal cord motor neurons contain a supersaturated proteome, as they possess proteins at concentrations that exceed their solubility limits, resulting in a metastable proteome conducive to protein misfolding and aggregation. Recent evidence indicates metastable sub-proteomes within neuronal compartments, such as the synapse, may be particularly vulnerable and underlie their involvement in the initial stages of neurodegenerative diseases. To investigate if the motor neuron presynaptic terminal possesses a metastable sub-proteome, we used human and mouse spinal cord motor neuron expression data to calculate supersaturation scores. Here, we found that both the human and mouse presynaptic terminal sub-proteomes have higher supersaturation scores than the entire motor neuron proteome. In addition, we observed that proteins down-regulated in ALS were over-represented in the synapse. These results provide support for the notion that the metastability of the sub-proteome within the motor neuron presynaptic terminal may be particularly susceptible to protein homeostasis disturbances in ALS, and may contribute to explaining the observed synaptic dysfunction in ALS.

Keywords: Metastability; Motor neuron; Presynaptic terminal; Protein homeostasis; Protein supersaturation; Synapse.

Similar articles

• The metastability of the proteome of spinal motor neurons underlies their selective vulnerability in ALS.

  Yerbury JJ, Ooi L, Blair IP, Ciryam P, Dobson CM, Vendruscolo M. Yerbury JJ, et al. Neurosci Lett. 2019 Jun 21;704:89-94. doi: 10.1016/j.neulet.2019.04.001. Epub 2019 Apr 3. Neurosci Lett. 2019. PMID: 30953736

• Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.

  Lasiene J, Komine O, Fujimori-Tonou N, Powers B, Endo F, Watanabe S, Shijie J, Ravits J, Horner P, Misawa H, Yamanaka K. Lasiene J, et al. Acta Neuropathol Commun. 2016 Feb 18;4:15. doi: 10.1186/s40478-016-0286-7. Acta Neuropathol Commun. 2016. PMID: 26891847 Free PMC article.

• Excitatory to inhibitory synaptic ratios are unchanged at presymptomatic stages in multiple models of ALS.

  Bonthron C, Burley S, Broadhead MJ, Metodieva V, Grant SGN, Chandran S, Miles GB. Bonthron C, et al. PLoS One. 2024 Aug 1;19(8):e0306423. doi: 10.1371/journal.pone.0306423. eCollection 2024. PLoS One. 2024. PMID: 39088455 Free PMC article.

• Proteome Homeostasis Dysfunction: A Unifying Principle in ALS Pathogenesis.

  Yerbury JJ, Farrawell NE, McAlary L. Yerbury JJ, et al. Trends Neurosci. 2020 May;43(5):274-284. doi: 10.1016/j.tins.2020.03.002. Epub 2020 Apr 14. Trends Neurosci. 2020. PMID: 32353332 Review.

• Proteostasis impairment and ALS.

  Lambert-Smith IA, Saunders DN, Yerbury JJ. Lambert-Smith IA, et al. Prog Biophys Mol Biol. 2022 Oct;174:3-27. doi: 10.1016/j.pbiomolbio.2022.06.001. Epub 2022 Jun 15. Prog Biophys Mol Biol. 2022. PMID: 35716729 Review.

Cited by

• Targeting GM2 Ganglioside Accumulation in Dementia: Current Therapeutic Approaches and Future Directions.

  Kumar S, Panda SP. Kumar S, et al. Curr Mol Med. 2024;24(11):1329-1345. doi: 10.2174/0115665240264547231017110613. Curr Mol Med. 2024. PMID: 37877564 Review.

• Misfolding at the synapse: A role in amyotrophic lateral sclerosis pathogenesis?

  Lum JS, Yerbury JJ. Lum JS, et al. Front Mol Neurosci. 2022 Sep 9;15:997661. doi: 10.3389/fnmol.2022.997661. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36157072 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal